Educational materials providing further information on generalised and partial lipodystrophy can be found below.
Generalised and partial Lipodystrophy
Lipodystrophy is a life-threatening, rare disease with many faces. This brochure gives you insights into the core characteristics and supportive clinical characteristics in generalised and partial lipodystrophy patients.
At ECE 2019, Aegerion Pharmaceuticals (now Amryt Pharmaceuticals) sponsored a symposium and meet the expert session on lipodystrophy. Content on these activities plus interviews with the panel are now available on touchENDOCRINOLOGY through the following link: